Input-output (I/O) functions for stimulus-frequency (SFOAE) and distortion-product (DPOAE) otoacoustic emissions were recorded in 30 normal-hearing adult ears using a nonlinear residual method. SFOAEs were recorded at half octaves from 500-8000 Hz in an L1=L2 paradigm with L2=0 to 85 dB SPL, and in a paradigm with L1 fixed and L2 varied. DPOAEs were elicited with primary levels of Kummer et al. [J. Acoust. Soc. Am. 103, 3431-3444 (1998)] at f2 frequencies of 2000 and 4000 Hz. Interpretable SFOAE responses were obtained from 1000-6000 Hz in the equal-level paradigm. SFOAE levels were larger than DPOAEs levels, signal-to-noise ratios were smaller, and I/O functions were less compressive. A two-slope model of SFOAE I/O functions predicted the low-level round-trip attenuation, the breakpoint between linearity and compression, and compressive slope. In ear but not coupler recordings, the noise at the SFOAE frequency increased with increasing level (above 60 dB SPL), whereas noise at adjacent frequencies did not. This suggests the existence of a source of signal-dependent noise producing cochlear variability, which is predicted to influence basilar-membrane motion and neural responses. A repeatable pattern of notched SFOAE I/O functions was present in some ears, and explained using a two-source mechanism of SFOAE generation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1121/1.1592799 | DOI Listing |
Nat Genet
January 2025
Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Genome-wide association studies have identified approximately 200 genetic risk loci for breast cancer, but the causal variants and target genes are mostly unknown. We sought to fine-map all known breast cancer risk loci using genome-wide association study data from 172,737 female breast cancer cases and 242,009 controls of African, Asian and European ancestry. We identified 332 independent association signals for breast cancer risk, including 131 signals not reported previously, and for 50 of them, we narrowed the credible causal variants down to a single variant.
View Article and Find Full Text PDFEur Arch Otorhinolaryngol
January 2025
Department of Otolaryngology, China-Japan Friendship Hospital, Beijing, China.
Objectives: This study examined the relationships between electrophysiological measures of the electrically evoked auditory brainstem response (EABR) with speech perception measured in quiet after cochlear implantation (CI) to identify the ability of EABR to predict postoperative CI outcomes.
Methods: Thirty-four patients with congenital prelingual hearing loss, implanted with the same manufacturer's CI, were recruited. In each participant, the EABR was evoked at apical, middle, and basal electrode locations.
Ear Hear
January 2025
Department of Otolaryngology, University Hospital Regensburg, Regensburg, Germany.
Objectives: Hearing aids (HAs) are a widely accepted first-line treatment option for individuals suffering from both hearing loss and chronic tinnitus. Though HAs are highly effective at improving speech understanding, their effectiveness in ameliorating tinnitus symptoms is less clear. In recent years, several investigators have reported on attempts to predict HAs effectiveness on tinnitus symptoms using an array of variables.
View Article and Find Full Text PDFPhysiol Rep
January 2025
Department of Physiology & Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Sympathoexcitation is a hallmark of heart failure, with sustained β-adrenergic receptor (βAR)-G protein signaling activation. βAR signaling is modulated by regulator of G protein signaling (RGS) proteins. Previously, we reported that Gα regulation by RGS2 or RGS5 is key to ventricular rhythm regulation, while the dual loss of both RGS proteins results in left ventricular (LV) dilatation and dysfunction.
View Article and Find Full Text PDFAdv Biomed Res
November 2024
Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: Escitalopram, a pharmacological compound, and crocin, the active compound of saffron, influence brain functions and serotonin levels. This study examined the efficacy of escitalopram with and without crocin in restoring the input-output (I/O) functions and long-term potentiation (LTP) within the hippocampal cornu ammonis 1 (CA1) region of stressed rats.
Materials And Methods: Rats were divided into six groups: control (Co), sham (Sh), stress-recovery (St-Rec), stress-escitalopram (St-Esc), stress-crocin (St-Cr), and stress-escitalopram-crocin (St-Esc-Cr) groups.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!